Deciding which patients with atopic dermatitis to prioritize for biologics and Janus kinase inhibitors
用户qgRSP4os3S6M
10天前
33
10
已完结
1. 系统已在2025-10-01 12:16:48对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
M Kamata, DI Sun, AS Paller
The Journal of Allergy and Clinical …, 2025
Elsevier
Atopic dermatitis (AD) is a common, chronic inflammatory skin … Biologics and Janus kinase (JAK) inhibitors are … that offer durable control by targeting the underlying skewing to type 2 …